Marker Therapeutics, Inc. Common Stock MRKR

$1.54 +2.67% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-14 View →
10-Q 10-Q 2026-05-15 View →
8-K FORM 8-K 2026-05-04 View →
DEF 14A FORM DEF 14A 2026-03-20 View →
8-K FORM 8-K 2026-03-19 View →
10-K 10-K 2026-03-18 View →
8-K FORM 8-K 2026-02-09 View →
4 PRIMARY DOCUMENT 2025-11-19 View →
4 PRIMARY DOCUMENT 2025-11-19 View →
4 OWNERSHIP DOCUMENT 2025-11-19 View →
8-K FORM 8-K 2025-11-14 View →
10-Q 10-Q 2025-11-13 View →
8-K FORM 8-K 2025-11-05 View →
4 PRIMARY DOCUMENT 2025-11-04 View →
4 PRIMARY DOCUMENT 2025-11-04 View →
8-K FORM 8-K 2025-10-06 View →
8-K FORM 8-K 2025-08-26 View →
10-Q 10-Q 2025-08-14 View →
8-K FORM 8-K 2025-08-12 View →
8-K FORM 8-K 2025-06-17 View →
8-K FORM 8-K 2025-06-09 View →
8-K FORM 8-K 2025-05-20 View →
10-Q 10-Q 2025-05-15 View →
DEF 14A FORM DEF 14A 2025-04-24 View →
8-K FORM 8-K 2025-03-31 View →
10-K 10-K 2025-03-31 View →
8-K FORM 8-K 2025-03-27 View →
8-K FORM 8-K 2025-02-19 View →
4 OWNERSHIP DOCUMENT 2025-02-14 View →
4 OWNERSHIP DOCUMENT 2025-02-14 View →
4 OWNERSHIP DOCUMENT 2025-02-14 View →
4 OWNERSHIP DOCUMENT 2025-02-14 View →
DEF 14A DEF 14A 2025-02-04 View →
8-K FORM 8-K 2025-01-30 View →
S-3 S-3 2025-01-10 View →
4 OWNERSHIP DOCUMENT 2024-12-26 View →
4 4 2024-12-23 View →
8-K FORM 8-K 2024-12-23 View →
8-K FORM 8-K 2024-12-19 View →
8-K FORM 8-K 2024-12-17 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$1.54
Market Cap
$25.01 million
52-Week Range
$0.81 – $2.46
Average Volume
62K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.